Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment OutcomesYasser Ged, Martin H. Voss, Robert J. Motzer et al.|Clinical Genitourinary Cancer|2019Cited by 63
Comprehensive Genomic Analysis of Metastatic Non–Clear-Cell Renal Cell Carcinoma to Identify Therapeutic TargetsMaria I. Carlo, Martin H. Voss, Nabeela Khan et al.|JCO Precision Oncology|2019Cited by 19
Alterations in key clear cell renal cell carcinoma (RCC) genes to refine patient prognosis.Dominick Bossé, Toni K. Choueiri, Wanling Xie et al.|Journal of Clinical Oncology|2018Cited by 9
Systemic therapy for advanced clear cell renal cell carcinoma (ccRCC) after progression on immune-oncology plus VEGF targeted therapy combinations (IO-VEGF).Yasser Ged, Chung‐Han Lee, Ruby Gupta et al.|Journal of Clinical Oncology|2019Cited by 5
Outcomes of metastatic chromophobe renal cell carcinoma (ChRCC) with sarcomatoid features (SF).Yasser Ged, Martin H. Voss, Andrea Knežević et al.|Journal of Clinical Oncology|2018Cited by 0